Abstract
Killing of HIV-infected cells by CD8+ T-cells imposes strong selection pressure on the virus toward escape. The HLA class I molecules that are successful in mediating some degree of control over the virus are those that tend to present epitopes in conserved regions of the proteome, such as in p24 Gag, in which escape also comes at a significant cost to viral replicative capacity (VRC). In some instances, compensatory mutations can fully correct for the fitness cost of such an escape variant; in others, correction is only partial. The consequences of these events within the HIV-infected host, and at the population level following transmission of escape variants, are discussed. The accumulation of escape mutants in populations over the course of the epidemic already shows instances of protective HLA molecules losing their impact, and in certain cases, a modest decline in HIV virulence in association with population-level increase in mutants that reduce VRC.
Highlights
Role of HLA Adaptation in Hiv evolutionSpecialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology
The ability of HIV to evade the immune response is one of the major challenges standing in the way of the development of a successful HIV vaccine
Certainly in Caucasian populations infected with B clade virus, any mutations within KK10 can safely be assumed to have been the result of selection pressure driven by this HLA-B*27 response
Summary
Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology. The HLA class I molecules that are successful in mediating some degree of control over the virus are those that tend to present epitopes in conserved regions of the proteome, such as in p24 Gag, in which escape comes at a significant cost to viral replicative capacity (VRC). Compensatory mutations can fully correct for the fitness cost of such an escape variant; in others, correction is only partial. The consequences of these events within the HIV-infected host, and at the population level following transmission of escape variants, are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have